Skip to main content

A kinase inhibitor screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative breast cancer to EGFR-targeted therapy

Access & Citations

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

Online attention

Altmetric score 5
  • 3 tweeters
  • 1 Facebook pages
  • 70 Mendeley

This article is in the 66th percentile (ranked 119,674th) of the 363,724 tracked articles of a similar age in all journals and the 35th percentile (ranked 17th) of the 28 tracked articles of a similar age in Breast Cancer Research

View more on Altmetric

Altmetric calculates a score based on the online attention an article receives. Each coloured thread in the circle represents a different type of online attention. The number in the centre is the Altmetric score. Social media and mainstream news media are the main sources that calculate the score. Reference managers such as Mendeley are also tracked but do not contribute to the score. Older articles often score higher because they have had more time to get noticed. To account for this, Altmetric has included the context data for other articles of a similar age.

Breast Cancer Research

ISSN: 1465-542X

Contact us